Us Bancorp \De\ Aligos Therapeutics, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.04 - $2.14 $1,880 - $3,869	-1,808 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$2.08 - $12.2 $1,501 - $8,808	722 Added 66.48%	1,808 $4,000
Q4 2021 Feb 11, 2022	BUY	$11.48 - $17.69 $7,726 - $11,905	673 Added 162.95%	1,086 $13,000
Q3 2021 Nov 10, 2021	BUY	$14.57 - $17.72 $5,740 - $6,981	394 Added 2073.68%	413 $6,000
Q2 2021 Aug 05, 2021	BUY	$20.3 - $33.6 $385 - $638	19 New	19 $0

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.